2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death

2,759 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

2020 ESC Guidelines for the management of adult congenital heart disease (2021, background): “ICD implantation for secondary prevention of SCD and for primary prevention in patients with biventricular physiology and a systemic LV follows standard criteria.(37,41) Antiarrhythmic drugs may be used as an adjunct to an ICD in order to reduce the ventricular arrhythmia burden.”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, unknown): “460 ms in women are suggested as a guideline for the upper limit of normal on baseline ECG evaluation.(156,157) QTc prolongation .”
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, methodology): “Primary prevention of sudden cardiac death with the ICD within 40 days after MI in the absence of VT/VF is generally not indicated.(3) Patients should be re-evaluated for ICD implantation 6–12 weeks after revascularization, although those with pre-existing impaired LVEF may be considered for ICD imp”